Navigation Links
VA Secretary Appoints Panel of National Suicide Experts
Date:5/21/2008

Goal Is Reducing Veterans' Suicides

WASHINGTON, May 21 /PRNewswire-USNewswire/ -- Secretary of Veterans Affairs Dr. James B. Peake today announced the names of members appointed to two special panels that will make recommendations on ways the Department of Veterans Affairs (VA) can improve its programs in suicide prevention, suicide research and suicide education.

"There is nothing more tragic than the death by suicide of even one of the great men or women who have served this nation," Peake said. "VA is committed to doing all we can to improve our understanding of a complicated issue that is also a national concern."

Membership in the first group, the "Blue Ribbon Work Group on Suicide Prevention in the Veterans Population," will be comprised of government experts in various suicide prevention and education programs. Those experts will come from agencies including the Department of Defense, the Centers for Disease Control, the National Institute of Health, and the Substance Abuse and Mental Health Services Administration.

The five-member work group is expected to meet from June 11-13, and will develop a report with recommendations for the Secretary within 15 days of meeting.

The second group is a nine-member expert panel, made up of nationally renowned experts in public health suicide programs, suicide research and clinical treatment programs, that will provide professional opinion, interpretation, and conclusions on information and data to the work group. It will also make recommendations to the work group on opportunities for improvement in VA's programs.

Secretary Peake initially announced the formation of the work group during testimony to the House Veterans Affairs Committee on May 6.

Members of the "Blue Ribbon Work Group on Suicide Prevention in the Veterans Population" include:

-- Cmdr. Alex E. Crosby, M.D., medical epidemiologist with the Centers for

Disease Control and Preven
'/>"/>

SOURCE U.S. Department of Veterans Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PA Secretary of Health Announces Emergency Medical Services Week, May 18 - 24
2. Secretary Leavitt Travels to the Peoples Republic of China to Check Up on Efforts to Improve Product Safety
3. PA Secretary of Health Reminds Women to Focus on Their Health During National Womens Health Week
4. PA Budget Secretary Says Future Retiree Health Care Costs Estimated at $8.5 Billion
5. Secretary Cortes Calls Latino Community to Action Against Ailing Health Care System
6. State Health Secretary Visits City of Chester for Cover the Uninsured Week
7. PA Secretary of Public Welfare Releases 2007 Child Abuse Report
8. Pennsylvania Health Secretary Focuses on Changing the Climate of Health Care During National Public Health Week
9. Statement by the White House Press Secretary
10. HHS Secretary Leavitt Praised for Defending Physicians Conscience Rights
11. HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...e University College of Medicine research team led...layer of regulation in the cell division cycle, wh...ay cancer begins. , Wang, an assistant professor..., said the findings will lead to an improved abili... of new drugs that kill cancer cells by inhibiting...
(Date:11/21/2008)...ewswire/ -- The Generic,Pharmaceutical Associatio...om,GPhA President and CEO Kathleen Jaeger regardi...on "Emerging Health Care Competition and Consumer ...onducting this roundtable demonstrates the,growin...ess to safe and,affordable biogenerics sooner rat...
(Date:11/21/2008)...USNewswire/ -- New research at West Virginia Univ... tobacco product aimed at young adults is catching...ds, Camel Snus - touted as a socially acceptable w...gh levels of nicotine. , , "Camel Snus cont..." said Bruce Adkins of the state Division of Tobac...
(Date:11/21/2008)...re-FirstCall/ -- Today, prescription drugs are the... 88 percent of patients suffering chronic conditio...onic condition account for 96 percent of all presc...l costs. A proprietary new pharmacy model develop.... (NYSE: MHS ) significantly reduces critical ga...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...h officials are all set to oil the wheels of retai...opose new regulations to allow for the operation o...lso encourage not-for-profit hospitals, community ... basic medical services. The proposed changes wer...
...ntified the first gene that is linked to Restless ...er that affects millions of people worldwide . RL...ering need to move the legs and is also a major ca...sleep disturbance. We now have concrete evidence t...
...from heart disease among younger Britons is slowin... research published ahead of print in the journal ...nary artery heart disease in England and Wales bet...gures.They used the data to calculate heart diseas...
...f more than a thousand prisoners has failed to sol...e and prisoner rehabilitation programmes, said th...niversary of the Ministry of Justices introduction...lleviate the overcrowding crisis in English and We...
Other Medicine News:Health News:Retail Health Clinics Start Shop 2Health News:Gene Linked With Restless Leg Syndrome Spotted Out 2Health News:Disquieting Slow Down in Heart Disease Deaths Among Under 55s 2Health News:Prison Healthcare Continues to Fail Despite Emergency Measures, Warns BMA 2
(Date:11/19/2008)...istical significance , , ISELIN, N.J., Nov.... (Nasdaq: PARS ) today announced results from it...ion (NE) drug delivery technology formulated with ...-center, randomized, double-blinded, placebo-contr...he Company,s 3% Diclofenac Diethanolamine NanoEmul...
(Date:11/18/2008)...all/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialt...nt Company,and Sosei Group Corporation ("Sosei";...l biopharmaceutical company, today announce that N...linical efficacy data for NSL-043/SD118.,This inv...pathic pain and has,successfully completed Phase ...
(Date:11/18/2008)...gnosed, elderly AML patients , , PRINCETON,...cals today announced that the first patient has be...of CPX-351 (Cytarabine:Daunorubicin) Liposome Inje...id leukemia (AML). , , The first patient wa...al College of Cornell University and New York Pre...
(Date:11/12/2008)...Watson, Marilyn & James Simons and,Sherry Lansing ... 12 J. Craig Venter,Ph...Institute (JCVI), was,awarded the Double Helix Med...vember 6th at a gala event in New York City., Dr.... Dr. James D.,Watson for making each of their indi...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ASTRO selects pediatric oncologist as 2008 honorary member 25838 1ASTRO selects pediatric oncologist as 2008 honorary member 25838 2Combination Therapy Helps to Combat Myeloma 25834 1Combination Therapy Helps to Combat Myeloma 25834 2Combination Therapy Helps to Combat Myeloma 25834 3Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 1Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 7358 2Iowa State University researcher shows proteins have controlled motions 4624 1Iowa State University researcher shows proteins have controlled motions 4624 2
...patients treated with VELCADE, cyclophosphamide,a...ne 28, 2007 /PRNewswire-FirstCall/ -- Millennium,P...ation of results,from clinical trials of VELCADE b... / complete response(1) (CR) rates in previously,t...ngs were,presented at the prestigious 11th Interna...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
Healon vitreous aspirating cannula, 21 gauge.
Flexible silicone tip cannula allows atraumatic access through retinal tear or hole for aspiration of subretinal fluids. Silicone tube extends 6mm beyond end of cannula. Luer lock hub for easy, sec
Ultra thin wall .90 mm (20 g) cannula allows maximum flow rate, 6 mm in length. Cannula beveled for easy insertion through sclerotomy. 3201 has 16 cm (6 in) high pressure PVC tubing to allow injectio
...ective line of compact CO2 systems combines portab...ature an extremely accurate laser beam, as well as...cially advantageous for small operating theatres a.... Use of special contact tips and accessories allo...
Medicine Products: